Merit WRAPSODY™ Endoprosthesis for Treatment of Stenosis or Occlusion (WRAP)
← catalyst calendarSponsored by Merit Medical Systems, Inc. (industry) · MMSI — their whole pipeline →.
Phase
—
Status
Active, not recruiting
Study type
Observational
Enrollment
500estimated
Sites
35
Countries
Australia, Brazil, Germany +6
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2022-06-23 | actual | When the study began enrolling |
| Primary completion | 2026-04-15 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2027-10-15 | estimated | The whole study's end, after follow-up |
| First posted | 2021-09-30 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-12-10 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Venous Stenosis
- Venous Occlusion
Intervention
- Device: Merit WRAPSODY Endovascular Stent Graft
Primary outcomes
what the primary-completion date above is the date OFProportion of subjects with Target Lesion Primary Patency (TLPP) (Primary Effectiveness Endpoint)
measured 6 months
Proportion of subjects without any localized or systemic safety events (Primary Safety Endpoint)
measured 30 days
Publications
- PMID 37592020 — linked by the registry
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · MMSI's whole pipeline · Catalyst calendar · Every registered study · What changed